Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2025-12-25 @ 8:23 PM
Study NCT ID:
NCT07260669
Status:
RECRUITING
Last Update Posted:
2025-12-03
First Post:
2025-09-29
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis
Sponsor:
Gesynta Pharma AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-10-15
Start Date Type:
ACTUAL
Primary Completion Date:
2027-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-06
Completion Date Type:
ESTIMATED
First Submit Date:
2025-09-29
First Submit QC Date:
None
Study First Post Date:
2025-12-03
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-28
Last Update Post Date:
2025-12-03
Last Update Post Date Type:
ESTIMATED